Which has grown faster, CBIO or CRMD?

Over the past five years, CRMD grew revenue faster — CBIO at a 39.89% CAGR versus CRMD at 352.03%.

Is CBIO or CRMD more profitable?

CRMD runs the higher net margin — CBIO at -1371.51% versus CRMD at 40.49%.

How have CBIO and CRMD total returns compared?

Over the past 10 years, CBIO delivered -22.94% and CRMD delivered -7.74% annualized total return. Past performance doesn't predict future results.

Crescent Biopharma, Inc. (CBIO) vs CorMedix Inc. (CRMD)

A side-by-side comparison of Crescent Biopharma, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CBIO

Crescent Biopharma, Inc.

$504M

$13.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CRMD

CorMedix Inc.

$571M

$7.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CBIO vs CRMD

growth of $100 · dividends reinvested · last 10y

CBIO -92.3% (-22.6%/yr)CRMD -48.3% (-6.4%/yr)CRMD compounded faster over this window

Log scale — wide-divergence pair

CBIO CRMD

CBIO vs CRMD: by the numbers

•CRMD is the larger company ($571M vs $504M market cap).
•CRMD is profitable (40.49% net margin) while CBIO runs a net loss (-1371.51%).
•CRMD grew revenue faster over the past five years (352.03% vs 39.89% CAGR).

Metrics side by side

Valuation

Metric	CBIO	CRMD
P/E ratio	N/A	3.42
Forward P/E	N/A	14.71
P/S ratio	42.42	1.24
P/B ratio	3.17	1.24
EV / EBITDA	N/A	1.82
FCF yield	N/A	43.82%

Profitability

Metric	CBIO	CRMD
Gross margin	100.00%	82.78%
Operating margin	-1407.52%	46.95%
Net margin	-1371.51%	40.49%
ROE	-99.83%	40.62%
ROIC	-102.59%	27.87%

Growth (annualized)

Metric	CBIO	CRMD
Revenue CAGR (5Y)	39.89%	352.03%
Total return CAGR (5Y)	-24.40%	9.70%

Frequently asked

Which has grown faster, CBIO or CRMD?: Over the past five years, CRMD grew revenue faster — CBIO at a 39.89% CAGR versus CRMD at 352.03%.
Is CBIO or CRMD more profitable?: CRMD runs the higher net margin — CBIO at -1371.51% versus CRMD at 40.49%.
How have CBIO and CRMD total returns compared?: Over the past 10 years, CBIO delivered -22.94% and CRMD delivered -7.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CBIO analysis Full CRMD analysis Interactive comparison tool

Dig into the metrics

CorMedix P/E ratio Crescent Biopharma ROE CorMedix ROE Crescent Biopharma operating margin CorMedix operating margin Crescent Biopharma revenue growth CorMedix revenue growth Crescent Biopharma free cash flow CorMedix free cash flow

Crescent Biopharma & CorMedix appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.